Allopurinol and diuretic-induced hyperuricaemia

Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer's dementia.

Drugs of today (Barcelona, Spain : 1998)·2016

Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia.

Drugs of today (Barcelona, Spain : 1998)·2016

Folate augmentation of antidepressant response.

Drugs of today (Barcelona, Spain : 1998)·2014

Bupivacaine liposome injectable suspension: a new approach to postsurgical pain.

Drugs of today (Barcelona, Spain : 1998)·2013

Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.

Drugs of today (Barcelona, Spain : 1998)·2013

Perampanel: a novel antiepileptic for the adjunctive treatment of refractory partial onset seizures.

Drugs of today (Barcelona, Spain : 1998)·2013

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

The why, what, who and when of B cell depletion in systemic lupus erythematosus: Biological rationale, patient stratification and evolving therapeutic modalities.

Rheumatology (Oxford, England)·2026

Immune checkpoint inhibitor-associated severe hyponatremia: evidence mapping of SIADH-like phenotypes and endocrine immune-related adverse events.

Endocrine connections·2026

Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

Giant cell arteritis during risankizumab therapy: a possible paradoxical reaction to IL-23 inhibition.

Immunological medicine·2026

Small Intestinal Extranodal Marginal Zone Lymphoma Mimicking Crohn's Disease.

ACG case reports journal·2026

A Pancreas Out of Place: Acute Interstitial Pancreatitis Caused by Pancreatic Herniation in a Type IV Paraesophageal Hernia.

ACG case reports journal·2026

Related Experiment Videos

Allopurinol and diuretic-induced hyperuricaemia

Related Concept Videos

Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer's dementia.

Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia.

Folate augmentation of antidepressant response.

Bupivacaine liposome injectable suspension: a new approach to postsurgical pain.

Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.

Perampanel: a novel antiepileptic for the adjunctive treatment of refractory partial onset seizures.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

The why, what, who and when of B cell depletion in systemic lupus erythematosus: Biological rationale, patient stratification and evolving therapeutic modalities.

Immune checkpoint inhibitor-associated severe hyponatremia: evidence mapping of SIADH-like phenotypes and endocrine immune-related adverse events.

Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients.

Giant cell arteritis during risankizumab therapy: a possible paradoxical reaction to IL-23 inhibition.

Small Intestinal Extranodal Marginal Zone Lymphoma Mimicking Crohn's Disease.

A Pancreas Out of Place: Acute Interstitial Pancreatitis Caused by Pancreatic Herniation in a Type IV Paraesophageal Hernia.

Related Experiment Videos

Allopurinol and diuretic-induced hyperuricaemia

Related Concept Videos

Related Articles